Data / Form D filings / Seraxis Holdings, Inc.
Seraxis Holdings, Inc.: Form D filings
Seraxis Holdings, Inc., a biotechnology company in Germantown, MD, filed 2 Form D notices with the SEC between 2021 and 2026. The latest, on September 24, 2026, reports $10 million sold of a $10 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20400 Century Boulavard Suite 150, Germantown, MD, 20874
- Phone
- (240) 780-8064
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1845486
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | New notice | $10,000,000 | $10,000,000 | 1 | Sep 7, 2026 | sec.gov | |
| Feb 23, 2021 | New notice | $40,000,000 | $14,000,011 | $25,999,989 | 5 | Jan 29, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William L. Rust | Executive Officer, Director | |
| Carole Welsch | Executive Officer | |
| Jerry Baty | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
Every Form D from the week of Sep 21, 2026 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Seraxis Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.